Class information for:
Level 1: DIPYRIDAMOLE//VASODILATOR DRUG//TUMOR CELL GROWTH AND VIABILITY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
19700 429 29.3 63%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
903 10618 DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DIPYRIDAMOLE Author keyword 21 14% 31% 133
2 VASODILATOR DRUG Author keyword 6 80% 1% 4
3 TUMOR CELL GROWTH AND VIABILITY Author keyword 4 67% 1% 4
4 ANTI CANC DRUG Address 3 35% 1% 6
5 DNA SYNTHESIS AND FRAGMENTATION Author keyword 2 67% 0% 2
6 PYRIMIDO PYRIMIDINE DERIVATIVES Author keyword 2 67% 0% 2
7 TRIPTYCENE BISQUINONES Author keyword 2 67% 0% 2
8 AGGRENOX R Author keyword 1 100% 0% 2
9 DIPYRIDAMOLE DERIVATIVE Author keyword 1 100% 0% 2
10 DIPYRIDAMOLE DERIVATIVES Author keyword 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DIPYRIDAMOLE 21 14% 31% 133 Search DIPYRIDAMOLE Search DIPYRIDAMOLE
2 VASODILATOR DRUG 6 80% 1% 4 Search VASODILATOR+DRUG Search VASODILATOR+DRUG
3 TUMOR CELL GROWTH AND VIABILITY 4 67% 1% 4 Search TUMOR+CELL+GROWTH+AND+VIABILITY Search TUMOR+CELL+GROWTH+AND+VIABILITY
4 DNA SYNTHESIS AND FRAGMENTATION 2 67% 0% 2 Search DNA+SYNTHESIS+AND+FRAGMENTATION Search DNA+SYNTHESIS+AND+FRAGMENTATION
5 PYRIMIDO PYRIMIDINE DERIVATIVES 2 67% 0% 2 Search PYRIMIDO+PYRIMIDINE+DERIVATIVES Search PYRIMIDO+PYRIMIDINE+DERIVATIVES
6 TRIPTYCENE BISQUINONES 2 67% 0% 2 Search TRIPTYCENE+BISQUINONES Search TRIPTYCENE+BISQUINONES
7 AGGRENOX R 1 100% 0% 2 Search AGGRENOX+R Search AGGRENOX+R
8 DIPYRIDAMOLE DERIVATIVE 1 100% 0% 2 Search DIPYRIDAMOLE+DERIVATIVE Search DIPYRIDAMOLE+DERIVATIVE
9 DIPYRIDAMOLE DERIVATIVES 1 100% 0% 2 Search DIPYRIDAMOLE+DERIVATIVES Search DIPYRIDAMOLE+DERIVATIVES
10 MOPIDAMOL 1 100% 0% 2 Search MOPIDAMOL Search MOPIDAMOL

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIOXIDANT DRUG DIPYRIDAMOLE 12 86% 1% 6
2 DIPYRIDAMOLE ANALOGS 9 83% 1% 5
3 DRUG DIPYRIDAMOLE 9 59% 2% 10
4 NUCLEOSIDE SALVAGE 3 50% 1% 4
5 BIFUNCTIONAL ANTICANCER DRUGS 3 60% 1% 3
6 THYMIDINE SALVAGE 2 67% 0% 2
7 5 FLUOROURACIL CYTO TOXICITY 2 50% 1% 3
8 NANOMOLAR RANGE 2 33% 1% 5
9 CAD GENE AMPLIFICATION 1 50% 0% 2
10 FLUOROURACIL METABOLISM 1 50% 0% 2

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel? 2014 2 49 33%
Dipyridamole: A Drug with Unrecognized Antioxidant Activity 2015 0 82 52%
Resistance to chemotherapeutic antimetabolites: A function of salvage pathway involvement and cellular response to DNA damage 1997 75 99 14%
DRUG-THERAPY - DIPYRIDAMOLE 1987 379 47 15%
ENHANCEMENT OF 5-FLUOROURACILS ANTICANCER ACTIVITY BY DIPYRIDAMOLE 1989 52 74 31%
Targeting the Inflammatory Response in Secondary Stroke Prevention: A Role for Combining Aspirin and Extended-release Dipyridamole 2009 11 27 11%
Tumor resistance to antimetabolites 1998 15 40 20%
Interferon-inducing effects of dipiridamol: antiviral and regulatory 2000 0 14 29%
EFFECTS OF DIPYRIDAMOLE INFUSION ON LOCAL PLATELET-AGGREGATION AND LOCAL FORMATION OF THROMBOXANE-A2 IN PATIENTS WITH PULMONARY-HYPERTENSION 1985 1 1 100%
NUCLEOSIDE SALVAGE AND RESISTANCE TO ANTIMETABOLITE ANTICANCER AGENTS 1991 28 84 13%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ANTI CANC DRUG 3 35% 1.4% 6
2 PHARMACOL TOXICOL CANC AOBA KU 1 100% 0.5% 2
3 EDIFICIO QUIM PROC 1 40% 0.5% 2
4 CLIN PROTE MASSACHUSETTS GEN HOSP 1 50% 0.2% 1
5 CHEM MFG CONTROL 1 22% 0.5% 2
6 PRECLIN DEV FORMULAT 0 33% 0.2% 1
7 QUIM MET TRANS 0 33% 0.2% 1
8 ANTICANC DRUG 0 10% 0.7% 3
9 GRP VILLA MARIA CARE 0 17% 0.2% 1
10 NEUROPROTECT MASSACHUSETTS GEN HOSP 0 17% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000155808 NUCLEOSIDE TRANSPORT//NITROBENZYLTHIOINOSINE//NUCLEOSIDE TRANSPORTER
2 0.0000147712 URIDINE PHOSPHORYLASE//5 PHENYLTHIOACYCLOURIDINE//ALPHA D RIBOSE 1 PHOSPHATE
3 0.0000107352 9 ALLYLPURINES//ANTIPLATELET COMPOUNDS//HAMILTON GEN HOSP CLIN UNIT
4 0.0000104491 SPONTANEOUS PLATELET AGGREGATION//PARTICLE COUNTING METHOD//AGGREGOMETER
5 0.0000092196 PRIMA CLIN MED//BIOMED EVOLUT AGING//CLIN LIPID
6 0.0000086472 MEVALONIC ACID//MEVALONATE 5 PYROPHOSPHATE DECARBOXYLASE//COMM HUMAN NUTR NUTRIT BIOL
7 0.0000061734 NAPHAZOLINE HYDROCHLORIDE//NAPHAZOLINE//GLAFENINE
8 0.0000054798 TRANSIENT ISCHEMIC ATTACK//ABCD2 SCORE//TIA
9 0.0000053095 BIOCHEMICAL MODULATION//LEUCOVORIN//FOLINIC ACID
10 0.0000051938 TIAZOFURIN//BENZAMIDE RIBOSIDE//IMPDH